Literature DB >> 31575297

Advances in phototherapy for psoriasis and atopic dermatitis.

Lajos Kemény1,2,3, Emese Varga1, Zoltan Novak4.   

Abstract

Introduction: Phototherapy has long been used for the treatment of inflammatory skin diseases, such as psoriasis and atopic dermatitis. The most frequent treatment approach utilizes ultraviolet (UV) light, however, recently, different lasers and low-level light therapies (LLLT) emitting wavelengths in the spectrum of the visible light have also been tried for the treatment of inflammatory skin diseases with variable success.Areas covered: This review provides an update on the different forms of phototherapy used for the treatment of psoriasis and atopic dermatitis. The proposed mechanism of action of the different phototherapeutical approaches are covered, including the immunosuppressive effect of UV light, the anti-inflammatory effect of vascular lasers and the LLLT induced photobiomodulation. The clinical efficacy of the different treatment options is also discussed.Expert opinion: Based on the efficacy and safety, NB-UVB represents the gold standard for treating psoriasis and atopic dermatitis. The UVB excimer laser and excimer lamp might be the best option for clearing localized therapy-resistant lesions. Home UV phototherapy systems might promote treatment adherence and better compliance of the patients. Vascular lasers, IPLs and LLLT, however, can not currently be recommended for the treatment of inflammatory skin diseases because of the lack of well-controlled studies.

Entities:  

Keywords:  Phototherapy; apoptosis; atopic dermatitis; cytokines; immunosuppression; laser; psoriasis; ultraviolet

Mesh:

Year:  2019        PMID: 31575297     DOI: 10.1080/1744666X.2020.1672537

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  8 in total

Review 1.  Visible light. Part I: Properties and cutaneous effects of visible light.

Authors:  Evan Austin; Amaris N Geisler; Julie Nguyen; Indermeet Kohli; Iltefat Hamzavi; Henry W Lim; Jared Jagdeo
Journal:  J Am Acad Dermatol       Date:  2021-02-25       Impact factor: 11.527

2.  Cannabidiol Effects on Phospholipid Metabolism in Keratinocytes from Patients with Psoriasis Vulgaris.

Authors:  Iwona Jarocka-Karpowicz; Michał Biernacki; Adam Wroński; Agnieszka Gęgotek; Elżbieta Skrzydlewska
Journal:  Biomolecules       Date:  2020-02-28

3.  The Differential Effect of Cannabidiol on the Composition and Physicochemical Properties of Keratinocyte and Fibroblast Membranes from Psoriatic Patients and Healthy People.

Authors:  Barbara Szachowicz-Petelska; Wojciech Łuczaj; Adam Wroński; Anna Jastrząb; Izabela Dobrzyńska
Journal:  Membranes (Basel)       Date:  2021-02-04

Review 4.  Carbon-Based Materials in Photodynamic and Photothermal Therapies Applied to Tumor Destruction.

Authors:  Karina J Lagos; Hilde H Buzzá; Vanderlei S Bagnato; María Paulina Romero
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

Review 5.  Ozone Layer Depletion and Emerging Public Health Concerns - An Update on Epidemiological Perspective of the Ambivalent Effects of Ultraviolet Radiation Exposure.

Authors:  Sheikh Ahmad Umar; Sheikh Abdullah Tasduq
Journal:  Front Oncol       Date:  2022-03-10       Impact factor: 6.244

Review 6.  Recognition of Melanocytes in Immuno-Neuroendocrinology and Circadian Rhythms: Beyond the Conventional Melanin Synthesis.

Authors:  Yan-Yan Chen; Li-Ping Liu; Hang Zhou; Yun-Wen Zheng; Yu-Mei Li
Journal:  Cells       Date:  2022-06-30       Impact factor: 7.666

Review 7.  NRF2 in dermatological disorders: Pharmacological activation for protection against cutaneous photodamage and photodermatosis.

Authors:  Shirin Kahremany; Lukas Hofmann; Arie Gruzman; Albena T Dinkova-Kostova; Guy Cohen
Journal:  Free Radic Biol Med       Date:  2022-06-23       Impact factor: 8.101

Review 8.  Contact dermatitis.

Authors:  Pamela L Scheinman; Marc Vocanson; Jacob P Thyssen; Jeanne Duus Johansen; Rosemary L Nixon; Kate Dear; Nina C Botto; Johanna Morot; Ari M Goldminz
Journal:  Nat Rev Dis Primers       Date:  2021-05-27       Impact factor: 52.329

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.